Arthritis Research & Therapy · 2017 · 27 citations · 17 references
Life SciencesImmunologyInternal MedicineAutoimmunityClinical ImmunologyRheumatologyAntibody CharacterizationAutoantibodiesAutoimmune Disease PathogenesisAutoimmune DiseasesAutoimmune Rheumatic DiseasesRheumatoid ArthritisAnti-cyclic Citrullinated Peptide AntibodiesAntibody SubclassesAutoantibodies In Rheumatic DiseaseDiagnostic PropertiesImmune Effector FunctionsImmune Effector MoleculesRheumatoid Arthritis DiagnosticsSeropositive Rheumatoid Arthritis
BACKGROUND: Anti-carbamylated protein (anti-CarP) antibodies have recently been reported to occur in around 45% of rheumatoid arthritis (RA) patients and to have prognostic and diagnostic properties. At present, the breadth and molecular make-up of the anti-CarP antibody response is ill defined. To understand the anti-CarP antibody immune response and potential immune effector mechanisms it can recruit, we determined the anti-CarP antibody isotype and IgG-subclass usage in RA patients. METHODS: Anti-CarP antibody IgM, IgA, and IgG or IgG subclasses were detected by enzyme-linked immunosorbent assay (ELISA) in sera from 373 unselected RA patients and 196 healthy controls. An additional 114 anti-citrullinated protein antibody (ACPA) and anti-CarP IgG double-positive patients were selected to study the concomitant presence of both antibody systems. RESULTS: Anti-CarP IgG was present in around 45% of the patients and comprised all anti-CarP IgG subclasses. The presence of anti-CarP IgG1 particularly associates with radiological damage. Anti-CarP IgM was detected in 16% of RA patients, even in anti-CarP IgG-positive individuals, and is indicative of an actively ongoing immune response. Around 45% of the patients were positive for IgA which included ACPA-positive cases but also 24% of the ACPA-negative cases. In ACPA and anti-CarP double-positive patients, the distribution and number of isotypes and IgG subclasses was similar for both autoantibodies at the group level, but substantial variation was observed within individual patient samples. CONCLUSIONS: In RA, the anti-CarP antibody response uses a broad spectrum of isotypes and seems to be an actively ongoing immune reaction. Furthermore, the anti-CarP and ACPA autoantibody responses seems to be differentially regulated.
17
D. Aletaha, Tuhina Neogi, Alan J. Silman et al. · Annals of the Rheumatic Diseases · 2010 · 4.9K citations · Full text
Medicine, Internal Medicine, Clinical Classification Systems +13
How to read radiographs according to the Sharp/van der Heijde method.
D. van der Heijde · PubMed · 1999 · 1.2K citations
Jing Shi, Rachel Knevel, Parawee Suwannalai et al. · Proceedings of the National Academy of Sciences · 2011 · 573 citations · Full text